Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Here’s a detailed, hour-by-hour action plan prioritizing patient safety, regulatory compliance, ethical obligations, and long-term corporate integrity while mitigating financial and reputational risks: Hour 0–4: Immediate Crisis Assessment Assemble the Core Crisis Team (1 hour) Include: Chief Medical Officer (CMO)…Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer